-+ 0.00%
-+ 0.00%
-+ 0.00%

How Aflac Stock And U.S. Life Insurers Look If 10 Year Yields Stay Above 5%

Simply Wall St·09/14/2026 23:31:30
语音播报

When the 10 year U.S. Treasury yield pushes above 5% and oil and inflation data keep the pressure on the Federal Reserve, retirement math quietly changes for insurers and their policyholders. That shift can create fresh risks for some portfolios while opening up new income angles for others. This article unpacks that tension and spotlights 3 large U.S. life insurance and annuity stocks exposed to this rate shock story.

The three stocks highlighted below are only a starter set. The full screen on Simply Wall St surfaced 14 more U.S. life insurers and retirement annuity providers with equally compelling business stories tied to long-term rates and income products. If you want to identify and analyze the higher conviction ideas across this space, head straight into the U.S. Life Insurers and Retirement Annuity Providers screener.

Primerica (PRI)

Overview: Primerica provides term life insurance and retirement-focused investment products to middle-income families, linking its business directly to long-term interest rates.

Operations: Primerica generates about US$1.8b from Term Life Insurance, US$1.4b from Investment and Savings Products, and US$233 million from other offerings.

Market Cap: US$9.0b

Primerica matters in this screener because it sits at the intersection of basic protection and retirement income products that react acutely to rate moves.

"Strong demographic drivers, especially the large cohort of Baby Boomers and Gen X approaching retirement, are associated with sustained demand for retirement planning products, annuities, and investment solutions. These factors provide a multi-year tailwind for Primerica's ISP segment and have supported double-digit sales growth."

What happens to that earnings mix if a single pressure on household budgets intensifies just as those retirement flows peak?

If that squeeze on household cash flow is the real swing factor, read the full narrative for Primerica to see how those pressures might be masking longer term earnings power.

NYSE:PRI Earnings & Revenue History as at Sep 2026
NYSE:PRI Earnings & Revenue History as at Sep 2026

Aflac (AFL)

Overview: Aflac provides supplemental health and life insurance that helps workers and families cover medical and income gaps, linking its earnings to the performance of a large, long-term investment portfolio.

Operations: Aflac generates about US$7.0b from Aflac U.S., US$8.9b from Aflac Japan, plus roughly US$1.2b from corporate and other activities and portfolio items.

Market Cap: US$57.8b

Aflac matters in this life and retirement screen because its supplemental policies are backed by a sizeable investment book that reacts directly to long-term interest rates, so changes in yields can reshape both the income it earns on assets and the value investors place on its future cash flows.

"The successful launch of new, customizable cancer insurance (Miraito) in Japan, coupled with strong early sales across all distribution channels, including banks and Japan Post, positions Aflac to capture demand for supplemental health coverage among aging and younger consumers, supporting topline revenue and premium growth."

What really tests that story is how one unresolved pressure on future margins plays out if rate tailwinds and product momentum ever diverge.

If that margin pressure ever bites, read the full narrative for Aflac to see how Aflac’s product engine and rate exposure could still reshape the long term story.

NYSE:AFL Earnings & Revenue History as at Sep 2026
NYSE:AFL Earnings & Revenue History as at Sep 2026

Pekin Life Insurance (PKIN)

Overview: Pekin Life Insurance provides life, annuity, and accident and health coverage in the U.S., linking long-term insurance promises to investment spreads.

Operations: The group currently reports a revenue loss of about $72 million from its life and health insurance line in the United States.

Market Cap: $201 million

Pekin Life Insurance focuses on long-duration policies and annuity style products in a world of higher long-term interest rates. However, it combines this thematic exposure with a small scale footprint, recent earnings weakness, and a fully externally funded balance sheet. Investors watching this sector may be particularly attentive to what happens if a single pressure on that funding model intensifies just as spreads widen.

As that funding question hangs over widening spreads, review the 4 warning signs (3 are major!) to see what may be masking Pekin Life Insurance’s next chapter.

OTCPK:PKIN Earnings & Revenue History as at Sep 2026
OTCPK:PKIN Earnings & Revenue History as at Sep 2026

Seeking Fresh Alternatives Before They Fly

Some of the strongest breakouts start quietly. Momentum builds, then prices move fast and the cleanest entry window drops away. Scan these fresh ideas before the crowd and consider them while they are still early.

  • Track income-heavy opportunities that keep paying even when sentiment cools by screening for a curated set of 6 dividend fortresses while yields still look appealing.
  • Hunt for potential infrastructure opportunities by zeroing in on 38 power grid technology and infrastructure stocks backed by real assets and grid upgrades that may attract attention before headlines catch up.
  • Spot under the radar growth stories in automation by focusing on a tight group of 38 robotics and automation stocks while valuations may still reward early research.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.